The naturally occurring YMDD mutation among patients chronically infected HBV and untreated with lamivudine: a systematic review and meta-analysis.
<h4>Background</h4>Several recent reports have demonstrated that tyrosine (Y)-methionine (M)-aspartic acid (D)-aspartic acid (D) (YMDD) motif mutations can naturally occur in chronic HBV patients without antiviral treatment such as lamivudine therapy. This paper aims to assess the overal...
Saved in:
| Main Authors: | Youwen Tan, Keqin Ding, Jing Su, Xuan Trinh, Zhihang Peng, Yuhua Gong, Li Chen, Qian Cui, Na Lei, Xin Chen, Rongbin Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2012-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0032789&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants
by: Sükran Köse, et al.
Published: (2011-03-01) -
QUANTITATION OF LAMIVUDINE BY UV SPECTROPHOTOMETRY
by: Y. A. Gonchikova, et al.
Published: (2017-07-01) -
Bayesian Analysis of Complex Mutations in HBV, HCV, and HIV Studies
by: Bing Liu, et al.
Published: (2019-09-01) -
Mutations in reverse transcriptase region of HBV affect Hepatitis B surface antigen titers and its correlation with HBV DNA
by: Hongyu Shen, et al.
Published: (2019-11-01) -
Compatibility Study of Lamivudine with Various Cellulose Polymers
by: P. Narayana Raju, et al.
Published: (2009-01-01)